A Woman with Plaques: Atypical Mycobacterial Infection Case Report
Main Article Content
Keywords
PPC, Mycobacterium, Phosphatidylcholine, Lipolysis, Self-injection
Abstract
Cosmetic enhancement products administered by injection are readily available online. These materials circumvent both the quality control manufacturing process and physician supervision. One of the most serious complications is infection with Mycobacterium abscessus. Described is the case of a forty-six-year-old female who purchased a compound promoted for dermal injection and subsequently developed a persistent skin infection with M. abscessus.
References
1. Noh Y, Heo CY. The effect of phosphatidylcholine and deoxycholate compound injections to the localized adipose tissue: an experimental study with a murine model. Arch Plast Surg. 2012;39(5):452-456. doi:10.5999/aps.2012.39.5.452
2. Ono S, Hyakusoku H. Complications after self-injection of hyaluronic acid and phosphatidylcholine for aesthetic purposes. Aesthet Surg J. 2010;30(3):442-445. doi:10.1177/1090820X10374088
3. Rizzo AR, Moniri NH. Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use. BMC Infect Dis. 2022;22(1):874. Published 2022 Nov 22. doi:10.1186/s12879-022-07857-7
4. Matsumoto Y, Fukano H, Hasegawa N, Hoshino Y, Sugita T. Quantitative evaluation of Mycobacterium abscessus clinical isolate virulence using a silkworm infection model. PLoS One. 2022;17(12):e0278773. Published 2022 Dec 20. doi:10.1371/journal.pone.0278773
5. Jong BE, Wu TS, Chen NY, et al. Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species. Microbiol Spectr. 2022;10(6):e0274922. doi:10.1128/spectrum.02749-22
2. Ono S, Hyakusoku H. Complications after self-injection of hyaluronic acid and phosphatidylcholine for aesthetic purposes. Aesthet Surg J. 2010;30(3):442-445. doi:10.1177/1090820X10374088
3. Rizzo AR, Moniri NH. Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use. BMC Infect Dis. 2022;22(1):874. Published 2022 Nov 22. doi:10.1186/s12879-022-07857-7
4. Matsumoto Y, Fukano H, Hasegawa N, Hoshino Y, Sugita T. Quantitative evaluation of Mycobacterium abscessus clinical isolate virulence using a silkworm infection model. PLoS One. 2022;17(12):e0278773. Published 2022 Dec 20. doi:10.1371/journal.pone.0278773
5. Jong BE, Wu TS, Chen NY, et al. Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species. Microbiol Spectr. 2022;10(6):e0274922. doi:10.1128/spectrum.02749-22